Skip to content
Disclosery

D. E. Shaw & Co., Inc.: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of D. E. Shaw & Co., Inc. on GMED, newest first. How the timeline and the estimate are built.

D. E. Shaw & Co., Inc. held 8,300 GMED shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 8,300 shares
    Change vs previous 13F -20,059 shares

    <0.01% of the 13F portfolio, value $655,783.

    13F-HR 0001104659-26-097217 filed by D. E. Shaw & Co., Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 28,359 shares
    Change vs previous 13F -59,850 shares

    <0.01% of the 13F portfolio, value $2,443,411.

    13F-HR 0001104659-26-062472 filed by D. E. Shaw & Co., Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 88,209 shares
    Change vs previous 13F -117,964 shares

    0.01% of the 13F portfolio, value $7,701,528.

    13F-HR 0001104659-26-016332 filed by D. E. Shaw & Co., Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 206,173 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $11,807,528.

    13F-HR 0001104659-25-112505 filed by D. E. Shaw & Co., Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).